pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Endpoints Announces Second Annual Health Tech Day with Virtual Sessions

Nov 3, 2026·read at Endpoints ↗Neutral

On Thursday, Endpoints will hold its second Health Tech Day, an event that brings together leaders in digital health.

Lydia Ramsey Pflanzer, the deputy editor, says she looks forward to traveling for the day, calling it her favorite of the year.

The conference will include both in-person and virtual sessions, expanding access for participants.

Readers are invited to sign up for free access to the article and to receive newsletters.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “The biggest conversations in health tech”

read at Endpoints ↗
75 words · retrieved 49m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoPfizer lifts 2026 guidance as cancer, migraine sales offset Covid slideEndpoints
  • 2h agoNovartis ends BioArctic pact; Two VC firms raise inaugural fundsEndpoints
  • 5h agoBayer CEO says company is ‘working on’ MFN in the USEndpoints
  • 7h agoUpdated: Merck KGaA is selling its CDMO business in the US to LonzaEndpoints
  • 21h agoAbbVie, Brise disclose deal for two preclinical migraine medsEndpoints